fda warning unapproved peptide products bpc-157 This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the will make FDA panel narrowly backs unapproved

Direct-to-Patient Value & Fair Pricing We choose not to participate in restrictive insurance networks so that our medical decisions are dictated by your needs, not an insurance adjuster's guidelines

Accelerated Recovery and Tissue Repair BPC-157 and TB-500 work through a different pathway-they reduce inflammation in tendons and joints while accelerating tissue repair

Degradation and fat-burning oxidation are activated by AOD 9604 in a way that does not involve HGH receptors

Store lyophilized AOD9604 at -20C

doi: 10.1016/j.neubiorev.2022.104847

Besides, we have partner factories that are responsible for commercial production in Jiangsu Province and Shandong Province